| UniProt ID | IL2RG_HUMAN | |
|---|---|---|
| UniProt AC | P31785 | |
| Protein Name | Cytokine receptor common subunit gamma | |
| Gene Name | IL2RG | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 369 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | Common subunit for the receptors for a variety of interleukins.. | |
| Protein Sequence | MLKPSLPFTSLLFLQLPLLGVGLNTTILTPNGNEDTTADFFLTTMPTDSLSVSTLPLPEVQCFVFNVEYMNCTWNSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGSNTSKENPFLFALEAVVISVGSMGLIISLLCVYFWLERTMPRIPTLKNLEDLVTEYHGNFSAWSGVSKGLAESLQPDYSERLCLVSEIPPKGGALGEGPGASPCNQHSPYWAPPCYTLKPET | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 24 | N-linked_Glycosylation | PLLGVGLNTTILTPN HHHCCEECCEEECCC | 29.28 | UniProtKB CARBOHYD | |
| 71 | N-linked_Glycosylation | VFNVEYMNCTWNSSS EEEEEEEECEECCCC | 21.11 | 16293754 | |
| 75 | N-linked_Glycosylation | EYMNCTWNSSSEPQP EEEECEECCCCCCCC | 17.54 | UniProtKB CARBOHYD | |
| 84 | N-linked_Glycosylation | SSEPQPTNLTLHYWY CCCCCCCEEEEEEEE | 37.40 | 16293754 | |
| 98 | Ubiquitination | YKNSDNDKVQKCSHY EECCCCHHHEEEHHH | 53.47 | - | |
| 101 | Ubiquitination | SDNDKVQKCSHYLFS CCCHHHEEEHHHHHC | 40.46 | 29967540 | |
| 119 | Ubiquitination | TSGCQLQKKEIHLYQ CCCCCCCCCEEEEEE | 62.05 | 29967540 | |
| 120 | Ubiquitination | SGCQLQKKEIHLYQT CCCCCCCCEEEEEEE | 49.27 | - | |
| 127 | O-linked_Glycosylation | KEIHLYQTFVVQLQD CEEEEEEEEEEECCC | 12.58 | OGP | |
| 147 | Ubiquitination | RQATQMLKLQNLVIP HHHHHHHHHHCCCCC | 42.56 | - | |
| 159 | N-linked_Glycosylation | VIPWAPENLTLHKLS CCCCCCCCCEEEECC | 36.95 | 16293754 | |
| 164 | Ubiquitination | PENLTLHKLSESQLE CCCCEEEECCHHHHH | 57.74 | - | |
| 198 | O-linked_Glycosylation | TDWDHSWTEQSVDYR CCCCCCCCCHHCCEE | 27.45 | OGP | |
| 204 | Phosphorylation | WTEQSVDYRHKFSLP CCCHHCCEEECCCCC | 16.68 | 26267517 | |
| 207 | Ubiquitination | QSVDYRHKFSLPSVD HHCCEEECCCCCCCC | 27.87 | 22505724 | |
| 217 | Ubiquitination | LPSVDGQKRYTFRVR CCCCCCCCEEEEEEE | 53.56 | - | |
| 249 | N-linked_Glycosylation | HPIHWGSNTSKENPF CCCCCCCCCCCCCCC | 44.42 | UniProtKB CARBOHYD | |
| 292 | Phosphorylation | RTMPRIPTLKNLEDL HHCCCCCCCCCHHHH | 48.25 | 9049783 | |
| 294 | Ubiquitination | MPRIPTLKNLEDLVT CCCCCCCCCHHHHHH | 63.06 | 22817900 | |
| 301 | Phosphorylation | KNLEDLVTEYHGNFS CCHHHHHHHHCCCHH | 37.82 | - | |
| 303 | Phosphorylation | LEDLVTEYHGNFSAW HHHHHHHHCCCHHHH | 12.98 | 19901323 | |
| 308 | Phosphorylation | TEYHGNFSAWSGVSK HHHCCCHHHHCCCCH | 32.59 | - | |
| 315 | Ubiquitination | SAWSGVSKGLAESLQ HHHCCCCHHHHHHHC | 56.38 | 22817900 | |
| 320 | Phosphorylation | VSKGLAESLQPDYSE CCHHHHHHHCCCCCC | 27.05 | 23401153 | |
| 325 | Phosphorylation | AESLQPDYSERLCLV HHHHCCCCCCCEEEE | 21.08 | 28796482 | |
| 326 | Phosphorylation | ESLQPDYSERLCLVS HHHCCCCCCCEEEEE | 24.50 | 23401153 | |
| 349 | Phosphorylation | LGEGPGASPCNQHSP CCCCCCCCCCCCCCC | 35.58 | 27080861 | |
| 355 | Phosphorylation | ASPCNQHSPYWAPPC CCCCCCCCCCCCCCC | 15.21 | 27080861 | |
| 357 | Phosphorylation | PCNQHSPYWAPPCYT CCCCCCCCCCCCCCC | 19.74 | 27259358 | |
| 363 | Phosphorylation | PYWAPPCYTLKPET- CCCCCCCCCCCCCC- | 22.38 | 19901323 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IL2RG_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IL2RG_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CPNS1_HUMAN | CAPNS1 | physical | 9326644 | |
| IL4RA_HUMAN | IL4R | physical | 12242343 | |
| JAK1_HUMAN | JAK1 | physical | 8041779 | |
| JAK2_HUMAN | JAK2 | physical | 8041779 | |
| I13R1_HUMAN | IL13RA1 | physical | 12207328 | |
| STK4_HUMAN | STK4 | physical | 21988832 | |
| KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
| NT2NL_HUMAN | NOTCH2NL | physical | 25416956 | |
| NFIP2_HUMAN | NDFIP2 | physical | 26186194 | |
| FLVC1_HUMAN | FLVCR1 | physical | 26186194 | |
| PTPRD_HUMAN | PTPRD | physical | 26186194 | |
| REEP6_HUMAN | REEP6 | physical | 26186194 | |
| IL2_HUMAN | IL2 | physical | 11418623 | |
| IL21_HUMAN | IL21 | physical | 11418623 | |
| REEP6_HUMAN | REEP6 | physical | 28514442 | |
| CD320_HUMAN | CD320 | physical | 28514442 | |
| PTPRD_HUMAN | PTPRD | physical | 28514442 | |
| FLVC1_HUMAN | FLVCR1 | physical | 28514442 | |
| JAK3_HUMAN | JAK3 | physical | 27742835 | |
| GRB10_HUMAN | GRB10 | physical | 27742835 | |
| NED4L_HUMAN | NEDD4L | physical | 27742835 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00080 | Systemic lupus erythematosus | |||||
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCI | |||||
| H00093 | Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndro | |||||
| OMIM Disease | ||||||
| 300400 | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) | |||||
| 312863 | X-linked combined immunodeficiency (XCID) | |||||
| Kegg Drug | ||||||
| D00748 | Aldesleukin (USAN/INN); Interleukin-2; Proleukin (TN) | |||||
| D02743 | Celmoleukin (genetical recombination) (JP16); Celmoleukin (INN); Celeuk (TN) | |||||
| D02749 | Teceleukin (genetical recombination) (JP16); Teceleukin (USAN); Imunace (TN) | |||||
| D03682 | Denileukin diftitox (USAN/INN); Ontak (TN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Crystal structure of the IL-2 signaling complex: paradigm for aheterotrimeric cytokine receptor."; Stauber D.J., Debler E.W., Horton P.A., Smith K.A., Wilson I.A.; Proc. Natl. Acad. Sci. U.S.A. 103:2788-2793(2006). Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 23-255 IN COMPLEX WITH IL2;IL2RA AND IL2RB, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-71; ASN-84AND ASN-159. | |
| "Structure of the quaternary complex of interleukin-2 with its alpha,beta, and gammac receptors."; Wang X., Rickert M., Garcia K.C.; Science 310:1159-1163(2005). Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 56-254 IN COMPLEX WITH IL2;IL2RA AND IL2RB, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-71; ASN-84AND ASN-159. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-292, AND MASSSPECTROMETRY. | |